Global menu

Our global pages


Eversheds shows its mettle on Zinc Ahead deal

  • United Kingdom


    Global law firm Eversheds has advised the shareholders of Oxford based Zinc Ahead on a growth equity investment from Accel-KKR, a technology-focused private equity firm based in Menlo Park, California.

    Zinc Ahead is the world's leading provider of marketing compliance solutions designed specifically for the life sciences industry. The company's flagship product, Zinc MAPS has already transformed compliance processes in more than 100 life sciences companies worldwide, demonstrating rapid efficiency and cost savings. Accel-KKR invests primarily in software and IT-enabled businesses well positioned for top-line and bottom-line growth.

    The Eversheds team was lead by Head of Private Equity Richard Moulton, assisted by Principal Associate Louise Finnie and Associate Simon Grimshaw. Tax advice was provided by Principal Associate Ben Jones and Associate Colin Askew.

    Richard Moulton said:

    “As a company, Zinc Ahead is committed to continuous innovation and product excellence which is why it is very much a leader in its field. It is no wonder that the company has courted investment from global tech investors such as Accel-KKR. This investment will accelerate Zinc Ahead’s plans for growth over the next few years and the company will benefit from Accel-KKR’s experience in the tech space.”

    James Brown, CEO and co-founder of Zinc Ahead, said:

    "Over the past dozen years, our company has generated strong growth as we have established Zinc MAPS as the gold standard marketing compliance solution designed specifically for the life sciences industry. The investment from Accel-KKR will enable Zinc to continue its growth on a global scale, especially in North America. The Accel-KKR team has deep knowledge of software and extensive experience investing alongside founder-led management teams, and they will be a tremendous partner as we continue to grow."


    This information is for guidance purposes only and should not be regarded as a substitute for taking legal advice. Please refer to the full terms and conditions on our website.

    < Go back

    Print Friendly and PDF
    Register to receive regular updates via email.